Centene (CNC) – Analysts’ Recent Ratings Changes

Centene (NYSE: CNC) has recently received a number of price target changes and ratings updates:

  • 11/17/2026 – Centene was given a new $90.00 price target by JPMorgan Chase & Co..
  • 11/17/2026 – Centene had its “outperform” rating reaffirmed by Sanford C. Bernstein. They now have a $90.00 price target on the stock.
  • 11/2/2026 – Centene had its “buy” rating reaffirmed by Truist Financial. They now have a $82.00 price target on the stock, up from $80.00.
  • 10/31/2026 – Centene was downgraded by Wall Street Zen from “strong-buy” to “buy”.
  • 10/30/2026 – Centene had its price target raised by Wells Fargo & Company from $69.00 to $75.00. They now have an “equal weight” rating on the stock.
  • 10/29/2026 – Centene had its “hold” rating reaffirmed by Jefferies Financial Group. They now have a $69.00 price target on the stock.
  • 10/29/2026 – Centene had its price target raised by JPMorgan Chase & Co. from $67.00 to $75.00. They now have a “neutral” rating on the stock.
  • 10/28/2026 – Centene was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
  • 10/28/2026 – Centene was given a new $79.00 price target by Raymond James Financial.
  • 10/28/2026 – Centene was given a new $71.00 price target by Morgan Stanley. They now have an “equal weight” rating on the stock.
  • 10/28/2026 – Centene was given a new $72.00 price target by Mizuho.
  • 10/28/2026 – Centene had its “buy” rating reaffirmed by Bank of America. They now have a $82.00 price target on the stock, up from $80.00.
  • 10/28/2026 – Centene had its price target raised by UBS Group from $70.00 to $78.00. They now have a “neutral” rating on the stock.
  • 10/28/2026 – Centene had its price target raised by Barclays from $80.00 to $82.00. They now have an “overweight” rating on the stock.
  • 10/28/2026 – Centene had its price target raised by Cantor Fitzgerald from $75.00 to $79.00. They now have an “overweight” rating on the stock.
  • 10/28/2026 – Centene had its price target raised by Robert W. Baird from $66.00 to $71.00. They now have a “neutral” rating on the stock.
  • 10/9/2026 – Centene had its “overweight” rating reaffirmed by Cantor Fitzgerald.
  • 10/8/2026 – Centene was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
  • 10/5/2026 – Centene was downgraded by Zacks Research from “strong-buy” to “hold”.

Centene Trading Down 2.8%

Shares of NYSE CNC traded down $1.89 during mid-day trading on Thursday, hitting $65.56. The stock had a trading volume of 5,531,592 shares, compared to its average volume of 5,672,108. The firm has a market cap of $32.46 billion, a P/E ratio of 22.45, a price-to-earnings-growth ratio of 0.42 and a beta of 1.07. The business has a 50 day moving average price of $67.45 and a two-hundred day moving average price of $56.94. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.16 and a current ratio of 1.16. Centene Corporation has a 1 year low of $31.63 and a 1 year high of $78.08.

Centene (NYSE:CNC – Get Free Report) last posted its quarterly earnings data on Tuesday, October 27th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.48. Centene had a return on equity of 12.15% and a net margin of 0.72%. The business had revenue of $50.65 billion during the quarter, compared to the consensus estimate of $47.12 billion. During the same quarter in the prior year, the company earned $0.50 earnings per share. The firm’s quarterly revenue was up 1.9% compared to the same quarter last year. On average, equities analysts anticipate that Centene Corporation will post 5.27 EPS for the current fiscal year.

Insider Activity at Centene

In other news, General Counsel Christopher Koster sold 56,500 shares of the company’s stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $66.90, for a total value of $3,779,850.00. Following the completion of the sale, the general counsel directly owned 248,854 shares in the company, valued at $16,648,332.60. This represents a 18.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.37% of the stock is owned by insiders.

Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.

Featured Stories

Receive News & Ratings for Centene Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene Corporation and related companies with MarketBeat.com's FREE daily email newsletter.